Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Atrial Septal Defect (ASD) Occluder Market Insights, Forecast to 2030
Global Atrial Septal Defect (ASD) Occluder Market Insights, Forecast to 2030
Industry: Medical Devices & Consumables
Published Date: 2024-04-13
Pages: 109 Pages
Report ld: 2939857
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Atrial Septal Defect (ASD) Occluder Market Size(US$)
CAGR 2024-2030
7.8%
Market Size,2030
USD 276.2
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 176 million
Market Forecast in 2030(Value)
US$ 276.2 million
CAGR
7.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
The global Atrial Septal Defect (ASD) Occluder market is projected to grow from US$ 176 million in 2024 to US$ 276.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
The US & Canada market for Atrial Septal Defect (ASD) Occluder is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Atrial Septal Defect (ASD) Occluder is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Atrial Septal Defect (ASD) Occluder is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Atrial Septal Defect (ASD) Occluder include Abbott, Gore Medical, AGA Medical Corporation, WEGO Introduction, Lepu Medical Technology (Beijing), LifeTech Scientific Corporation, Beijing Starway Medical, Dongguan Kewei and Beijing Balance Medical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Atrial Septal Defect (ASD) Occluder, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Atrial Septal Defect (ASD) Occluder, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Atrial Septal Defect (ASD) Occluder, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Atrial Septal Defect (ASD) Occluder sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Atrial Septal Defect (ASD) Occluder market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Atrial Septal Defect (ASD) Occluder sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Abbott
- Gore Medical
- AGA Medical Corporation
- WEGO Introduction
- Lepu Medical Technology (Beijing)
- LifeTech Scientific Corporation
- Beijing Starway Medical
- Dongguan Kewei
- Beijing Balance Medical
- Shanghai Push Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 4-10 mm
- 10-20 mm
- 20-30 mm
- 30-40 mm
- Other
Segment by Application
- Hospital
- Clinic
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Atrial Septal Defect (ASD) Occluder in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Atrial Septal Defect (ASD) Occluder manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atrial Septal Defect (ASD) Occluder sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Atrial Septal Defect (ASD) Occluder Product Introduction
1.2 Market by Type
1.2.1 Global Atrial Septal Defect (ASD) Occluder Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 4-10 mm
1.2.3 10-20 mm
1.2.4 20-30 mm
1.2.5 30-40 mm
1.2.6 Other
1.3 Market by Application
1.3.1 Global Atrial Septal Defect (ASD) Occluder Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Atrial Septal Defect (ASD) Occluder Sales Estimates and Forecasts 2019-2030
2.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Region
2.2.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Region (2019-2024)
2.2.3 Global Atrial Septal Defect (ASD) Occluder Revenue by Region (2025-2030)
2.2.4 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region (2019-2030)
2.3 Global Atrial Septal Defect (ASD) Occluder Sales Estimates and Forecasts 2019-2030
2.4 Global Atrial Septal Defect (ASD) Occluder Sales by Region
2.4.1 Global Atrial Septal Defect (ASD) Occluder Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Atrial Septal Defect (ASD) Occluder Sales by Region (2019-2024)
2.4.3 Global Atrial Septal Defect (ASD) Occluder Sales by Region (2025-2030)
2.4.4 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Atrial Septal Defect (ASD) Occluder Sales by Manufacturers
3.1.1 Global Atrial Septal Defect (ASD) Occluder Sales by Manufacturers (2019-2024)
3.1.2 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atrial Septal Defect (ASD) Occluder in 2023
3.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Manufacturers
3.2.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Manufacturers (2019-2024)
3.2.2 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Atrial Septal Defect (ASD) Occluder Revenue in 2023
3.3 Global Key Players of Atrial Septal Defect (ASD) Occluder, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Atrial Septal Defect (ASD) Occluder Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Atrial Septal Defect (ASD) Occluder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Product Offered and Application
3.8 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Atrial Septal Defect (ASD) Occluder Sales by Type
4.1.1 Global Atrial Septal Defect (ASD) Occluder Historical Sales by Type (2019-2024)
4.1.2 Global Atrial Septal Defect (ASD) Occluder Forecasted Sales by Type (2025-2030)
4.1.3 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2019-2030)
4.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Type
4.2.1 Global Atrial Septal Defect (ASD) Occluder Historical Revenue by Type (2019-2024)
4.2.2 Global Atrial Septal Defect (ASD) Occluder Forecasted Revenue by Type (2025-2030)
4.2.3 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2019-2030)
4.3 Global Atrial Septal Defect (ASD) Occluder Price by Type
4.3.1 Global Atrial Septal Defect (ASD) Occluder Price by Type (2019-2024)
4.3.2 Global Atrial Septal Defect (ASD) Occluder Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Atrial Septal Defect (ASD) Occluder Sales by Application
5.1.1 Global Atrial Septal Defect (ASD) Occluder Historical Sales by Application (2019-2024)
5.1.2 Global Atrial Septal Defect (ASD) Occluder Forecasted Sales by Application (2025-2030)
5.1.3 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2019-2030)
5.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Application
5.2.1 Global Atrial Septal Defect (ASD) Occluder Historical Revenue by Application (2019-2024)
5.2.2 Global Atrial Septal Defect (ASD) Occluder Forecasted Revenue by Application (2025-2030)
5.2.3 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2019-2030)
5.3 Global Atrial Septal Defect (ASD) Occluder Price by Application
5.3.1 Global Atrial Septal Defect (ASD) Occluder Price by Application (2019-2024)
5.3.2 Global Atrial Septal Defect (ASD) Occluder Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Atrial Septal Defect (ASD) Occluder Market Size by Type
6.1.1 US & Canada Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2030)
6.1.2 US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2030)
6.2 US & Canada Atrial Septal Defect (ASD) Occluder Market Size by Application
6.2.1 US & Canada Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2030)
6.2.2 US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2030)
6.3 US & Canada Atrial Septal Defect (ASD) Occluder Market Size by Country
6.3.1 US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Atrial Septal Defect (ASD) Occluder Sales by Country (2019-2030)
6.3.3 US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Atrial Septal Defect (ASD) Occluder Market Size by Type
7.1.1 Europe Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2030)
7.1.2 Europe Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2030)
7.2 Europe Atrial Septal Defect (ASD) Occluder Market Size by Application
7.2.1 Europe Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2030)
7.2.2 Europe Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2030)
7.3 Europe Atrial Septal Defect (ASD) Occluder Market Size by Country
7.3.1 Europe Atrial Septal Defect (ASD) Occluder Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Atrial Septal Defect (ASD) Occluder Sales by Country (2019-2030)
7.3.3 Europe Atrial Septal Defect (ASD) Occluder Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Atrial Septal Defect (ASD) Occluder Market Size
8.1.1 China Atrial Septal Defect (ASD) Occluder Sales (2019-2030)
8.1.2 China Atrial Septal Defect (ASD) Occluder Revenue (2019-2030)
8.2 China Atrial Septal Defect (ASD) Occluder Market Size by Application
8.2.1 China Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2030)
8.2.2 China Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Atrial Septal Defect (ASD) Occluder Market Size by Type
9.1.1 Asia Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2030)
9.1.2 Asia Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2030)
9.2 Asia Atrial Septal Defect (ASD) Occluder Market Size by Application
9.2.1 Asia Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2030)
9.2.2 Asia Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2030)
9.3 Asia Atrial Septal Defect (ASD) Occluder Sales by Region
9.3.1 Asia Atrial Septal Defect (ASD) Occluder Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Atrial Septal Defect (ASD) Occluder Revenue by Region (2019-2030)
9.3.3 Asia Atrial Septal Defect (ASD) Occluder Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Market Size by Type
10.1.1 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Market Size by Application
10.2.1 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Country
10.3.1 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Abbott Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Gore Medical
11.2.1 Gore Medical Company Information
11.2.2 Gore Medical Overview
11.2.3 Gore Medical Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Gore Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gore Medical Recent Developments
11.3 AGA Medical Corporation
11.3.1 AGA Medical Corporation Company Information
11.3.2 AGA Medical Corporation Overview
11.3.3 AGA Medical Corporation Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AGA Medical Corporation Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AGA Medical Corporation Recent Developments
11.4 WEGO Introduction
11.4.1 WEGO Introduction Company Information
11.4.2 WEGO Introduction Overview
11.4.3 WEGO Introduction Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 WEGO Introduction Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 WEGO Introduction Recent Developments
11.5 Lepu Medical Technology (Beijing)
11.5.1 Lepu Medical Technology (Beijing) Company Information
11.5.2 Lepu Medical Technology (Beijing) Overview
11.5.3 Lepu Medical Technology (Beijing) Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Lepu Medical Technology (Beijing) Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lepu Medical Technology (Beijing) Recent Developments
11.6 LifeTech Scientific Corporation
11.6.1 LifeTech Scientific Corporation Company Information
11.6.2 LifeTech Scientific Corporation Overview
11.6.3 LifeTech Scientific Corporation Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 LifeTech Scientific Corporation Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LifeTech Scientific Corporation Recent Developments
11.7 Beijing Starway Medical
11.7.1 Beijing Starway Medical Company Information
11.7.2 Beijing Starway Medical Overview
11.7.3 Beijing Starway Medical Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Beijing Starway Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Starway Medical Recent Developments
11.8 Dongguan Kewei
11.8.1 Dongguan Kewei Company Information
11.8.2 Dongguan Kewei Overview
11.8.3 Dongguan Kewei Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Dongguan Kewei Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dongguan Kewei Recent Developments
11.9 Beijing Balance Medical
11.9.1 Beijing Balance Medical Company Information
11.9.2 Beijing Balance Medical Overview
11.9.3 Beijing Balance Medical Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Beijing Balance Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Beijing Balance Medical Recent Developments
11.10 Shanghai Push Medical
11.10.1 Shanghai Push Medical Company Information
11.10.2 Shanghai Push Medical Overview
11.10.3 Shanghai Push Medical Atrial Septal Defect (ASD) Occluder Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Shanghai Push Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai Push Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Atrial Septal Defect (ASD) Occluder Industry Chain Analysis
12.2 Atrial Septal Defect (ASD) Occluder Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Atrial Septal Defect (ASD) Occluder Production Mode & Process
12.4 Atrial Septal Defect (ASD) Occluder Sales and Marketing
12.4.1 Atrial Septal Defect (ASD) Occluder Sales Channels
12.4.2 Atrial Septal Defect (ASD) Occluder Distributors
12.5 Atrial Septal Defect (ASD) Occluder Customers
13 Market Dynamics
13.1 Atrial Septal Defect (ASD) Occluder Industry Trends
13.2 Atrial Septal Defect (ASD) Occluder Market Drivers
13.3 Atrial Septal Defect (ASD) Occluder Market Challenges
13.4 Atrial Septal Defect (ASD) Occluder Market Restraints
14 Key Findings in The Global Atrial Septal Defect (ASD) Occluder Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Atrial Septal Defect (ASD) Occluder Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 4-10 mm
Table 3. Major Manufacturers of 10-20 mm
Table 4. Major Manufacturers of 20-30 mm
Table 5. Major Manufacturers of 30-40 mm
Table 6. Major Manufacturers of Other
Table 7. Global Atrial Septal Defect (ASD) Occluder Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Atrial Septal Defect (ASD) Occluder Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Atrial Septal Defect (ASD) Occluder Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Atrial Septal Defect (ASD) Occluder Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region (2019-2024)
Table 12. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region (2025-2030)
Table 13. Global Atrial Septal Defect (ASD) Occluder Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Atrial Septal Defect (ASD) Occluder Sales by Region (2019-2024) & (K Units)
Table 15. Global Atrial Septal Defect (ASD) Occluder Sales by Region (2025-2030) & (K Units)
Table 16. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Region (2019-2024)
Table 17. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Region (2025-2030)
Table 18. Global Atrial Septal Defect (ASD) Occluder Sales by Manufacturers (2019-2024) & (K Units)
Table 19. Global Atrial Septal Defect (ASD) Occluder Sales Share by Manufacturers (2019-2024)
Table 20. Global Atrial Septal Defect (ASD) Occluder Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 21. Global Atrial Septal Defect (ASD) Occluder Revenue Share by Manufacturers (2019-2024)
Table 22. Global Key Players of Atrial Septal Defect (ASD) Occluder, Industry Ranking, 2022 VS 2023 VS 2024
Table 23. Atrial Septal Defect (ASD) Occluder Price by Manufacturers 2019-2024 (US$/Unit)
Table 24. Global Atrial Septal Defect (ASD) Occluder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Atrial Septal Defect (ASD) Occluder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atrial Septal Defect (ASD) Occluder as of 2023)
Table 26. Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Product Offered and Application
Table 28. Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2024) & (K Units)
Table 31. Global Atrial Septal Defect (ASD) Occluder Sales by Type (2025-2030) & (K Units)
Table 32. Global Atrial Septal Defect (ASD) Occluder Sales Share by Type (2019-2024)
Table 33. Global Atrial Septal Defect (ASD) Occluder Sales Share by Type (2025-2030)
Table 34. Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Atrial Septal Defect (ASD) Occluder Revenue Share by Type (2019-2024)
Table 37. Global Atrial Septal Defect (ASD) Occluder Revenue Share by Type (2025-2030)
Table 38. Atrial Septal Defect (ASD) Occluder Price by Type (2019-2024) & (US$/Unit)
Table 39. Global Atrial Septal Defect (ASD) Occluder Price Forecast by Type (2025-2030) & (US$/Unit)
Table 40. Global Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2024) & (K Units)
Table 41. Global Atrial Septal Defect (ASD) Occluder Sales by Application (2025-2030) & (K Units)
Table 42. Global Atrial Septal Defect (ASD) Occluder Sales Share by Application (2019-2024)
Table 43. Global Atrial Septal Defect (ASD) Occluder Sales Share by Application (2025-2030)
Table 44. Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2024) & (US$ Million)
Table 45. Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2025-2030) & (US$ Million)
Table 46. Global Atrial Septal Defect (ASD) Occluder Revenue Share by Application (2019-2024)
Table 47. Global Atrial Septal Defect (ASD) Occluder Revenue Share by Application (2025-2030)
Table 48. Atrial Septal Defect (ASD) Occluder Price by Application (2019-2024) & (US$/Unit)
Table 49. Global Atrial Septal Defect (ASD) Occluder Price Forecast by Application (2025-2030) & (US$/Unit)
Table 50. US & Canada Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2024) & (K Units)
Table 51. US & Canada Atrial Septal Defect (ASD) Occluder Sales by Type (2025-2030) & (K Units)
Table 52. US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2024) & (US$ Million)
Table 53. US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Type (2025-2030) & (US$ Million)
Table 54. US & Canada Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2024) & (K Units)
Table 55. US & Canada Atrial Septal Defect (ASD) Occluder Sales by Application (2025-2030) & (K Units)
Table 56. US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2024) & (US$ Million)
Table 57. US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Application (2025-2030) & (US$ Million)
Table 58. US & Canada Atrial Septal Defect (ASD) Occluder Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Country (2019-2024) & (US$ Million)
Table 60. US & Canada Atrial Septal Defect (ASD) Occluder Revenue by Country (2025-2030) & (US$ Million)
Table 61. US & Canada Atrial Septal Defect (ASD) Occluder Sales by Country (2019-2024) & (K Units)
Table 62. US & Canada Atrial Septal Defect (ASD) Occluder Sales by Country (2025-2030) & (K Units)
Table 63. Europe Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2024) & (K Units)
Table 64. Europe Atrial Septal Defect (ASD) Occluder Sales by Type (2025-2030) & (K Units)
Table 65. Europe Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2024) & (US$ Million)
Table 66. Europe Atrial Septal Defect (ASD) Occluder Revenue by Type (2025-2030) & (US$ Million)
Table 67. Europe Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2024) & (K Units)
Table 68. Europe Atrial Septal Defect (ASD) Occluder Sales by Application (2025-2030) & (K Units)
Table 69. Europe Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2024) & (US$ Million)
Table 70. Europe Atrial Septal Defect (ASD) Occluder Revenue by Application (2025-2030) & (US$ Million)
Table 71. Europe Atrial Septal Defect (ASD) Occluder Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 72. Europe Atrial Septal Defect (ASD) Occluder Revenue by Country (2019-2024) & (US$ Million)
Table 73. Europe Atrial Septal Defect (ASD) Occluder Revenue by Country (2025-2030) & (US$ Million)
Table 74. Europe Atrial Septal Defect (ASD) Occluder Sales by Country (2019-2024) & (K Units)
Table 75. Europe Atrial Septal Defect (ASD) Occluder Sales by Country (2025-2030) & (K Units)
Table 76. China Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2024) & (K Units)
Table 77. China Atrial Septal Defect (ASD) Occluder Sales by Type (2025-2030) & (K Units)
Table 78. China Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2024) & (US$ Million)
Table 79. China Atrial Septal Defect (ASD) Occluder Revenue by Type (2025-2030) & (US$ Million)
Table 80. China Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2024) & (K Units)
Table 81. China Atrial Septal Defect (ASD) Occluder Sales by Application (2025-2030) & (K Units)
Table 82. China Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2024) & (US$ Million)
Table 83. China Atrial Septal Defect (ASD) Occluder Revenue by Application (2025-2030) & (US$ Million)
Table 84. Asia Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2024) & (K Units)
Table 85. Asia Atrial Septal Defect (ASD) Occluder Sales by Type (2025-2030) & (K Units)
Table 86. Asia Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2024) & (US$ Million)
Table 87. Asia Atrial Septal Defect (ASD) Occluder Revenue by Type (2025-2030) & (US$ Million)
Table 88. Asia Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2024) & (K Units)
Table 89. Asia Atrial Septal Defect (ASD) Occluder Sales by Application (2025-2030) & (K Units)
Table 90. Asia Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2024) & (US$ Million)
Table 91. Asia Atrial Septal Defect (ASD) Occluder Revenue by Application (2025-2030) & (US$ Million)
Table 92. Asia Atrial Septal Defect (ASD) Occluder Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 93. Asia Atrial Septal Defect (ASD) Occluder Revenue by Region (2019-2024) & (US$ Million)
Table 94. Asia Atrial Septal Defect (ASD) Occluder Revenue by Region (2025-2030) & (US$ Million)
Table 95. Asia Atrial Septal Defect (ASD) Occluder Sales by Region (2019-2024) & (K Units)
Table 96. Asia Atrial Septal Defect (ASD) Occluder Sales by Region (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Type (2019-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Type (2025-2030) & (K Units)
Table 99. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Type (2019-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Type (2025-2030) & (US$ Million)
Table 101. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Application (2019-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Application (2025-2030) & (K Units)
Table 103. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Application (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Application (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 106. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Country (2019-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales by Country (2025-2030) & (K Units)
Table 110. Abbott Company Information
Table 111. Abbott Description and Major Businesses
Table 112. Abbott Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Abbott Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Abbott Recent Developments
Table 115. Gore Medical Company Information
Table 116. Gore Medical Description and Major Businesses
Table 117. Gore Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Gore Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Gore Medical Recent Developments
Table 120. AGA Medical Corporation Company Information
Table 121. AGA Medical Corporation Description and Major Businesses
Table 122. AGA Medical Corporation Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. AGA Medical Corporation Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. AGA Medical Corporation Recent Developments
Table 125. WEGO Introduction Company Information
Table 126. WEGO Introduction Description and Major Businesses
Table 127. WEGO Introduction Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. WEGO Introduction Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. WEGO Introduction Recent Developments
Table 130. Lepu Medical Technology (Beijing) Company Information
Table 131. Lepu Medical Technology (Beijing) Description and Major Businesses
Table 132. Lepu Medical Technology (Beijing) Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Lepu Medical Technology (Beijing) Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Lepu Medical Technology (Beijing) Recent Developments
Table 135. LifeTech Scientific Corporation Company Information
Table 136. LifeTech Scientific Corporation Description and Major Businesses
Table 137. LifeTech Scientific Corporation Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. LifeTech Scientific Corporation Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. LifeTech Scientific Corporation Recent Developments
Table 140. Beijing Starway Medical Company Information
Table 141. Beijing Starway Medical Description and Major Businesses
Table 142. Beijing Starway Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Beijing Starway Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Beijing Starway Medical Recent Developments
Table 145. Dongguan Kewei Company Information
Table 146. Dongguan Kewei Description and Major Businesses
Table 147. Dongguan Kewei Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Dongguan Kewei Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Dongguan Kewei Recent Developments
Table 150. Beijing Balance Medical Company Information
Table 151. Beijing Balance Medical Description and Major Businesses
Table 152. Beijing Balance Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Beijing Balance Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Beijing Balance Medical Recent Developments
Table 155. Shanghai Push Medical Company Information
Table 156. Shanghai Push Medical Description and Major Businesses
Table 157. Shanghai Push Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Shanghai Push Medical Atrial Septal Defect (ASD) Occluder Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Shanghai Push Medical Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Atrial Septal Defect (ASD) Occluder Distributors List
Table 163. Atrial Septal Defect (ASD) Occluder Customers List
Table 164. Atrial Septal Defect (ASD) Occluder Market Trends
Table 165. Atrial Septal Defect (ASD) Occluder Market Drivers
Table 166. Atrial Septal Defect (ASD) Occluder Market Challenges
Table 167. Atrial Septal Defect (ASD) Occluder Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Atrial Septal Defect (ASD) Occluder Product Picture
Figure 2. Global Atrial Septal Defect (ASD) Occluder Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Atrial Septal Defect (ASD) Occluder Market Share by Type in 2023 & 2030
Figure 4. 4-10 mm Product Picture
Figure 5. 10-20 mm Product Picture
Figure 6. 20-30 mm Product Picture
Figure 7. 30-40 mm Product Picture
Figure 8. Other Product Picture
Figure 9. Global Atrial Septal Defect (ASD) Occluder Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Atrial Septal Defect (ASD) Occluder Market Share by Application in 2023 & 2030
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Atrial Septal Defect (ASD) Occluder Report Years Considered
Figure 15. Global Atrial Septal Defect (ASD) Occluder Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Atrial Septal Defect (ASD) Occluder Revenue 2019-2030 (US$ Million)
Figure 17. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 18. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region (2019-2030)
Figure 19. Global Atrial Septal Defect (ASD) Occluder Sales 2019-2030 ((K Units)
Figure 20. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Region (2019-2030)
Figure 21. US & Canada Atrial Septal Defect (ASD) Occluder Sales YoY (2019-2030) & (K Units)
Figure 22. US & Canada Atrial Septal Defect (ASD) Occluder Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Europe Atrial Septal Defect (ASD) Occluder Sales YoY (2019-2030) & (K Units)
Figure 24. Europe Atrial Septal Defect (ASD) Occluder Revenue YoY (2019-2030) & (US$ Million)
Figure 25. China Atrial Septal Defect (ASD) Occluder Sales YoY (2019-2030) & (K Units)
Figure 26. China Atrial Septal Defect (ASD) Occluder Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Asia (excluding China) Atrial Septal Defect (ASD) Occluder Sales YoY (2019-2030) & (K Units)
Figure 28. Asia (excluding China) Atrial Septal Defect (ASD) Occluder Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales YoY (2019-2030) & (K Units)
Figure 30. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue YoY (2019-2030) & (US$ Million)
Figure 31. The Atrial Septal Defect (ASD) Occluder Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 32. The Top 5 and 10 Largest Manufacturers of Atrial Septal Defect (ASD) Occluder in the World: Market Share by Atrial Septal Defect (ASD) Occluder Revenue in 2023
Figure 33. Global Atrial Septal Defect (ASD) Occluder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 34. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2019-2030)
Figure 35. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2019-2030)
Figure 36. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2019-2030)
Figure 37. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2019-2030)
Figure 39. US & Canada Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2019-2030)
Figure 40. US & Canada Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2019-2030)
Figure 41. US & Canada Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2019-2030)
Figure 42. US & Canada Atrial Septal Defect (ASD) Occluder Revenue Share by Country (2019-2030)
Figure 43. US & Canada Atrial Septal Defect (ASD) Occluder Sales Share by Country (2019-2030)
Figure 44. U.S. Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 45. Canada Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 46. Europe Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2019-2030)
Figure 47. Europe Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2019-2030)
Figure 48. Europe Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2019-2030)
Figure 49. Europe Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2019-2030)
Figure 50. Europe Atrial Septal Defect (ASD) Occluder Revenue Share by Country (2019-2030)
Figure 51. Europe Atrial Septal Defect (ASD) Occluder Sales Share by Country (2019-2030)
Figure 52. Germany Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 53. France Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 54. U.K. Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 55. Italy Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 56. Russia Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 57. China Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2019-2030)
Figure 58. China Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2019-2030)
Figure 59. China Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2019-2030)
Figure 60. China Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2019-2030)
Figure 61. Asia Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2019-2030)
Figure 62. Asia Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2019-2030)
Figure 63. Asia Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2019-2030)
Figure 64. Asia Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2019-2030)
Figure 65. Asia Atrial Septal Defect (ASD) Occluder Revenue Share by Region (2019-2030)
Figure 66. Asia Atrial Septal Defect (ASD) Occluder Sales Share by Region (2019-2030)
Figure 67. Japan Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 68. South Korea Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 69. China Taiwan Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 70. Southeast Asia Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 71. India Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Revenue Share by Country (2019-2030)
Figure 77. Middle East, Africa and Latin America Atrial Septal Defect (ASD) Occluder Sales Share by Country (2019-2030)
Figure 78. Brazil Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 79. Mexico Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 80. Turkey Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 81. Israel Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 82. GCC Countries Atrial Septal Defect (ASD) Occluder Revenue (2019-2030) & (US$ Million)
Figure 83. Atrial Septal Defect (ASD) Occluder Value Chain
Figure 84. Atrial Septal Defect (ASD) Occluder Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Atrial Septal Defect (ASD) Occluder in 2030?
The global market size of Atrial Septal Defect (ASD) Occluder in 2030 was 276.2 Million USD.
Which companies rank high in the global Atrial Septal Defect (ASD) Occluder market?
What was the global market size of Atrial Septal Defect (ASD) Occluder in 2024?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Atrial Septal Defect (ASD) Occluder market size from 2024 to 2030?
Related Reports
Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2026
The global Atrial Septal Defect (ASD) Occluder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 117
USD 2900.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Atrial Septal Defect (ASD) Occluder market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 79
USD 4250.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Atrial Septal Defect (ASD) Occluder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 138
USD 4900.00
(Single User License)
Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 95
USD 3950.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2025
The global market for Atrial Septal Defect (ASD) Occluder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 80
USD 2900.00
(Single User License)
Global Atrial Septal Defect (ASD) Occluder Market Research Report 2024
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published Date: 2024-02-21
Pages: 88
USD 2900.00
(Single User License)
Atrial Septal Defect (ASD) Occluder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-09
Pages: 97
USD 3950.00
(Single User License)
Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 128
USD 3950.00 (Single User License)Global Atrial Septal Defect (ASD) Occluder Market Research Report 2026
The global Atrial Septal Defect (ASD) Occluder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 117
USD 2900.00 (Single User License)Global Atrial Septal Defect (ASD) Occluder Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Atrial Septal Defect (ASD) Occluder market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 79
USD 4250.00 (Single User License)Global Atrial Septal Defect (ASD) Occluder Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Atrial Septal Defect (ASD) Occluder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 138
USD 4900.00 (Single User License)Atrial Septal Defect (ASD) Occluder- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 95
USD 3950.00 (Single User License)Global Atrial Septal Defect (ASD) Occluder Market Research Report 2025
The global market for Atrial Septal Defect (ASD) Occluder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 80
USD 2900.00 (Single User License)Global Atrial Septal Defect (ASD) Occluder Market Research Report 2024
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published: 2024-02-21
Pages: 88
USD 2900.00 (Single User License)Atrial Septal Defect (ASD) Occluder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-09
Pages: 97
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now